iShares Neuroscience and ... (IBRN)
NYSEArca: IBRN
· Echtzeitkurs · USD
39.64
+0.00 (0.00%)
Zum Schluss: Aug 18, 2026, 9:46 AM
iShares Neuroscience and Healthcare ETF (IBRN) ETF Price, Holdings & Analysis
0.00% (1D)
| Geld | 39.51 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 5.49 Mio |
| NAV | 39.14 |
| Beta | 0.9 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 28.53 |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Aug 24, 2022 |
| Brief | 39.63 |
| Volumen | 236 |
| Ø Vol. (20D) | 3,191 |
| Eröffnung | 39.55 |
| Vortagesschluss | 39.64 |
| Tagesspanne | 39.55 - 39.64 |
| 52-Wk Range | 24.12 - 43.01 |
| Positionen | k.A. |
| Kostenquote | 0.47% |
Über IBRN
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
Anlageklasse Equity
Tickersymbol IBRN
Auflagedatum Aug 24, 2022
Anbieter Ishares
Website Fonds-Homepage
Börse NYSEArca
Top 10 Positionen 45.44% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Dianthus Therapeutic... | DNTH | 5.34% |
| Xenon Pharmaceutical... | XENE | 4.87% |
| Praxis Precision Med... | PRAX | 4.87% |
| Acadia Pharmaceutica... | ACAD | 4.69% |
| Arrowhead Pharmaceut... | ARWR | 4.65% |
| Alkermes PLC | ALKS | 4.60% |
| Scholar Rock Holding... | SRRK | 4.29% |
| Biogen Inc | BIIB | 4.18% |
| Neurocrine Bioscienc... | NBIX | 4.09% |
| Argenx Se Adr | ARGX | 3.86% |
Dividenden Dividendenrendite 0.81%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Dec 16, 2025 | $0.3200 | k.A. |
| Dec 17, 2024 | $0.1010 | k.A. |
| Dec 20, 2023 | $0.0060 | k.A. |
| Jun 7, 2023 | $0.0080 | k.A. |
